FDA
-
-
-
-
-
-
-
FDA clears Implantica's RefluxStop implant for U.S. market
-
-
-
-
-
-
-
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma
-
-
-
-
-
-
-
Agilent receives FDA approval for colorectal cancer diagnostic test
-
-
-
-
-
-
-
Agilent Technologies (A) Unveils Biopharma CDx Services Lab to Accelerate Precision Medicine
-
-
-
-
-
-
-
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
-
-
-
-
-
-
-
Agilent Resolution ctDx FIRST Receives FDA Approval as a Liquid Biopsy Companion Diagnostic Test for Advanced Non-small Cell Lung Cancer
-
-
-
-
-
-
-
Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer
-
336,070 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


